Anti-estrogenic activity of a human resveratrol metabolite.
about
Anticancer Molecular Mechanisms of ResveratrolEffects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention.Herb-drug interactions: challenges and opportunities for improved predictions.Interplay between metabolism and transport of resveratrol.Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults.Anti-proliferative effects of quercetin and catechin metabolites.Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells.Amino Acid Carbamates As Prodrugs Of Resveratrol.Lack of glucuronidation products of trans-resveratrol in plasma and urine of cats.Therapeutic Versatility of Resveratrol Derivatives.Scientific Opinion on the risks for human and animal health related to the presence of modified forms of certain mycotoxins in food and feedMetabolism and pharmacokinetics of resveratrol and pterostilbene.Human-relevant potency threshold (HRPT) for ERα agonism.Resveratrol Protects Against Pathological Preterm Birth by Suppression of Macrophage-Mediated Inflammation.N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of ResveratrolNew Water-Soluble Carbamate Ester Derivatives of ResveratrolIncreased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles
P2860
Q26752323-130FC800-E8DD-41C2-8EBB-0E22C8E7653DQ33771427-DE3DBC33-B978-4991-8EBD-E3980D46AC0FQ37603890-BA3D0514-75DE-4F50-A9FB-CDC5EAD8FA83Q38121602-EF74B461-9730-46FC-82ED-44CFD598729BQ38245598-4505DE53-E9C0-4FD5-A5D3-6DCEA28FCA60Q38741510-F756299F-3D7E-4E69-B774-23FDC4844915Q39020623-8FE6B1D2-6B05-46A0-881E-354F84C47B75Q39069444-24B7AAF4-3123-49E9-A85C-A5E52837A649Q42592297-1771D217-B2B7-4A2E-B233-066C89B54720Q46935052-1FC099DE-8058-428C-BDBB-42AAA263541CQ47126437-4A59E568-5F9C-481D-8DDE-8E9F939B4371Q47163111-88D4861B-3F6D-45AF-9C3A-C4D796C07875Q47189418-6D76E1C1-BEFD-44AE-BDDA-E0AA6B9CDF97Q52690952-CF091831-41F6-4056-A004-2184C99EF0B1Q53480409-96D2ECFE-EEB5-4A09-A1A2-CE4F31BA6BFCQ57974082-8992AFA4-6438-4ED0-8366-F7915F0B1923Q57974104-6A807C5E-A26A-411B-BD41-CBE972648AFFQ58723030-BA7CB8D8-4534-4FAE-812A-9C3477C51120
P2860
Anti-estrogenic activity of a human resveratrol metabolite.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-estrogenic activity of a human resveratrol metabolite.
@en
Anti-estrogenic activity of a human resveratrol metabolite.
@nl
type
label
Anti-estrogenic activity of a human resveratrol metabolite.
@en
Anti-estrogenic activity of a human resveratrol metabolite.
@nl
prefLabel
Anti-estrogenic activity of a human resveratrol metabolite.
@en
Anti-estrogenic activity of a human resveratrol metabolite.
@nl
P2093
P50
P1476
Anti-estrogenic activity of a human resveratrol metabolite.
@en
P2093
P304
P356
10.1016/J.NUMECD.2013.01.002
P577
2013-03-05T00:00:00Z